View this email in your browser Feature: Champignon Brands Who: Champignon Brands Inc. is a publicly-traded research-driven company specializing in the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine industries. Capital Snapshot:

CSE: SHRM , OTC: SHRMF , FSE: 496

Share Price: C$0.305

Shares Outstanding: 61,737,688

Market Cap: C$18.8M

52W Low/High: $0.18 / $0.45

Company Investor Presentation Recent News: Announced Normal Course Issuer Bid for up to 5% of the issued common shares of the company. Press Release

Entered in to Definitive Agreement to acquire Novo Formulations Ltd, a specialty biotechnology company focused on developing novel and innovative delivery systems for the pharmaceutical and nutraceutical industries. Press Release

Entered in to Definitive Agreement to acquire Artisan Growers, a BC-based craft mushroom cultivator and supplier. Press Release Why: Champignon Brands has positioned themselves uniquely ahead of the curve in the Psychedelic and plant based products universe. With a flagship brand, Vitality SuperTeas , and the recent purchase of Artisan Growers , their wholly owned CPG product line is diverse and robust.



With the recent acquisitions of important IP around ketamine delivery systems , Champignon is establishing itself as a first mover in psychedelic medicine. Looking ahead, they are well capitalized to continue to find accretive deals around science, IP and innovation.